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Summary 
Adenoviruses (AdVs) cause respiratory, ocular and gastro-intestinal tract infections and 
inflammations in immuno-competent people, and life-threatening disease upon immuno-
suppression. AdV vectors are widely used in gene therapy and vaccination. Incoming 
particles attach to nuclear pore complexes (NPCs) of post-mitotic cells, rupture, and 
deliver viral DNA (vDNA) to the nucleus and misdeliver to the cytosol. Our genome-wide 
RNA-interference screen in AdV infected cells identified the RING-type E3-ubiquitin ligase 
Mind bomb 1 (Mib1) as a proviral host factor for AdV infection. Mib1 is implicated in 
Notch/Delta signalling, ciliary biogenesis, and RNA innate immunity. Mib1 depletion 
arrested incoming AdVs at NPCs. Induced expression of full-length but not ligase-defective 
Mib1 in knockout cells triggered the vDNA uncoating from NPC-tethered virions, nuclear 
import, misdelivery of vDNA, and vDNA expression. Mib1 is an essential host factor for 
AdV uncoating in human cells, and provides a new concept for licensing virion DNA 
delivery through the NPC.  
Highlights 
- Genome-wide RNAi screen identifies host factors boosting or inhibiting AdV 
entry  
- The E3 ubiquitin ligase Mib1 enhances the entry of AdV from different 
species 
- Ubiquitination activity of Mib1 licenses AdV uncoating at the nuclear pore 
complex 
- Mib1 at NPC-docked AdV releases viral DNA into nucleus and cytosol ‘on 
demand’ 
 
 
eTOC blurb 
Adenoviruses infect multiple organs in humans, delivering their DNA genome 
for replication to the nucleus. Adenovirus vectors are widely used in clinics. 
Bauer et al. identify a novel mechanism for virion-DNA uncoating at the 
nuclear pore complex, licenced by the E3 ubiquitin ligase activity of Mind 
bomb 1.  
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Introduction 
Molecular interactions in virus infected cells control the outcome of infection. Signalling 
events from the virus particle, virion to the cell affect for example nutrient sensing 
pathways, cell cycle progression, growth, migration, anti-viral immunity, cell survival and 
death. In turn, virions receive chemical and mechanical cues from the invaded cell, and 
thereupon engage a controlled, stepwise destabilization process, which culminates in the 
uncoating of the genome (Wolfrum and Greber, 2013; Yamauchi and Greber, 2016). In 
most cases, the dismantling starts upon receptor binding at the plasma membrane, and 
continues in endosomes, the cytoplasm and the nucleus until the genome is completely 
uncoated (Flatt and Greber, 2017; Marsh and Helenius, 2006; Wang et al., 2018; Witte et 
al., 2018).  
Viruses deliver their genome into the nucleus of post-mitotic cells by hijacking the nuclear 
import machinery and the nuclear pore complex (NPC). The NPC provides a size-limited 
passageway between the cytoplasm and the nucleoplasm (Kim et al., 2018; Schmidt and 
Gorlich, 2016). It restricts the import of most viral capsids, with the exception of very small 
capsids, such as parvoviruses and circoviruses (Kobiler et al., 2012). Hepatitis B virus with 
a similarly small capsid is thought to enter the NPC and dissociate its closed circular and 
partly double-stranded DNA within the NPC by a spring-loaded mechanism (Dhason et al., 
2012). Virion mechanics are implicated in releasing the pressurized DNA genome from 
herpesvirus capsids, and also entropically confined genomes in adenovirus (AdV) particles 
at the NPC (Greber, 2016; Shahin et al., 2006).  
AdVs are widespread and cause a variety of infections in vertebrates, including fish, 
repitiles, rodents, birds, non-human primates and humans (Davison et al., 2003). Human 
AdVs infect the respiratory and gastrointestinal tracts, the kidney, liver, eye as well as 
blood cells, and persist in lymphoid cells of the digestive tract, and can cause inflammatory 
disease (Cook and Radke, 2017). The human AdV species C type 2 or 5 (AdV-C2/5) 
particles enclose a linear double-stranded DNA of  ̴36 kbp in an icosahedral capsid of  ̴90 
nm. In the stepwise entry process, they shed the fibers and pentons, expose the 
membrane lytic protein VI, rupture the endosome and engage in cytoplasmic transport to 
the nuclear envelope docking to the NPC and releasing the genome for nuclear import 
along with protein VII, which is assembled with the vDNA in a nucleosome-like structure 
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(Burckhardt et al., 2011; Cassany et al., 2015; Greber et al., 1993; Luisoni et al., 2015; 
Moyer et al., 2011; Ostapchuk et al., 2017; Trotman et al., 2001; Wang et al., 2017; 
Wiethoff et al., 2005). The partly dismantled virions rupture at the NPC by mechanical 
force from microtubule-dependent motors (Strunze et al., 2011), and release the genome 
to the nucleus for transcription, but also misdeliver vDNA to the cytosol (Puntener et al., 
2011; Wang et al., 2013). Misdelivered DNA is decoded by cytosolic DNA sensors, such 
as cGAS and the inflammasome (Lam et al., 2014), which explains at least in part the 
inflammatory nature of AdV infections in a broad range of cell types, including immune 
cells (Greber and Flatt, 2019). The intricate entry process involves a plethora of host 
factors, most of which are unknown. Here, we conducted a genome-wide RNA-
interference screen in human cells infected with AdV-C2. We identified a novel licensing 
factor for viral genome uncoating at the NPC, the E3-ubiquitin ligase Mind bomb 1 (Mib1), 
and show that the ligase activity controls the nuclear import and cytoplasmic misdelivery of 
vDNA from AdV-C2/5.   
 
Results and Discussion 
Genome-wide RNA interference against AdV infection  
In search for new host factors involved in AdV entry and gene expression, we performed 
an arrayed genome-wide, image-based small interfering (si) RNA screen using four 
siRNAs combined per gene in HeLa cells. Dissecting molecular functions of cells by RNA 
interference (RNAi) screens is a powerful yet inherently noisy procedure with off-target 
effects due to cell toxicity of the siRNAs or their functioning as microRNAs with a broad 
range of targets (Daga et al., 2018; Franceschini et al., 2014). Genome-wide RNAi 
screens were reported for a range of viruses, including human immune deficiency virus, 
hepatitis C virus, Ebola virus, West Nile virus, vaccinia virus, influenza A virus, 
papillomavirus, enterovirus 71, bunyavirus, Semliki Forest virus, rotavirus and adeno-
associated virus, but not AdV (Balistreri et al., 2014; Goff, 2008; Green and Pelkmans, 
2016; Hao et al., 2013; Karlas et al., 2010; Krishnan et al., 2008; Li et al., 2009; Lipovsky 
et al., 2013; Mano et al., 2015; Meier et al., 2014; Smith et al., 2010; Su et al., 2013; 
Watanabe et al., 2010; Wu et al., 2016).  
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Here we provide the first genome-wide RNAi screen for AdV. Cells were infected with 
AdV-C2 encoding GFP under a CMV promoter in place of the E3B gene region (AdV-C2-
∆E3B-CMV-GFP) at a multiplicity of infection (MOI) of 0.1 (Yakimovich et al., 2012), 
stained with DAPI and phalloidin to label the cytoplasmic F-actin, imaged in a high-
throughput microscope, and analyzed for GFP expression 16 h post infection (pi) (Fig. 1A). 
The procedure was similar to a previous siRNA screen of the human kinome with a range 
of pathogens, including AdV-C2-dE3B-GFP (Ramo et al., 2014). Z-score analyses of 
16’462 host genes indicated a continuous distribution of hits, where 159 siRNA pools gave 
Z scores smaller than -2 (inhibiting infection) and 440 larger than +2 (enhancing infection) 
in an overall range from -2.99 to +6.51 (Fig. 1B, and Supplemental Table 1). The top 500 
siRNAs downregulating infection gave Z-scores < -1.57 (Supplemental Table 2). Grouping 
these hits into functional clusters using STRING (Szklarczyk et al., 2017) gave low false 
discovery rates smaller than 10-4 in case of the COP-I coated vesicle machinery, NPC 
components, the mediator complex, spliceosomal complex, cytosolic ribosomes, 
preribosomes, or the nucleolus, which are directly or indirectly involved in gene expression 
and protein production (Supplemental Fig. 1A) (Berk, 2005; Vijayalingam and Chinnadurai, 
2013). The top 500 siRNAs upregulating infection had Z-scores > +1.91 (Supplemental 
Table 3), and comprised broadly defined clusters, such as endo-lysosomal membranes, 
intracellular organelles, or protein-protein complexes with high false discovery rates 
between 0.01 and 0.05. These hits may reflect the fact that HeLa cells have compromised 
anti-viral defense, for example due to expression of the human papilloma virus E6 and E7 
proteins, which antagonize p53, pRb, or cyclic GMP-AMP synthase (see Supplemental 
Fig. 1B, and Lau et al., 2015; Mantovani and Banks, 2001; Munger et al., 2001). 
The E3 Ub ligase Mib1 controlling developmental signalling and innate 
immunity is broadly required for AdV infection 
We analyzed siRNA hits downregulating AdV infection, particularly those not affecting host 
gene expression and protein synthesis, and focussed on one of the strongest hits in our 
validation, the E3 ubiquitin (Ub) ligase Mib1. Mib1 is a RING (really interesting new gene)-
type E3 Ub ligase of 1006 amino acids, first discovered in Zebrafish and highly conserved 
in almost all higher organisms (Deshaies and Joazeiro, 2009). It localizes to centriolar 
satellite complexes on microtubules in the vicinity of the centrosome (Villumsen et al., 
2013). Ubiquitination can have a strong impact on the structure, function, localization, and 
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stability of the targeted protein, and viruses have evolved to exploit ubiquitination 
(Komander and Rape, 2012; Luo, 2016). For example, the Ub-proteasome system has 
been implicated in entry of dengue virus, Kaposi’s sarcoma-associated herpesvirus, 
vaccinia virus and influenza virus (Banerjee et al., 2014; Dejarnac et al., 2018; Greene et 
al., 2012; Gschweitl et al., 2016; Mercer et al., 2012; Su et al., 2013). Human AdVs have 
also been shown to manipulate the cellular ubiquitination machinery during replication 
(Orazio et al., 2011; Querido et al., 2001; Schreiner et al., 2010). Yet, a role for a specific 
E3 Ub ligase in virion dismantling has remained elusive.  
Our RNA interference against the E3 Ub ligase Mib1 strongly reduced AdV infection but 
not cell numbers, with infection and cell number Z-scores of -2.15 and +0.54, respectively 
(Supplemental Table 1). Four different siRNAs for Mib1 independently depleted the Mib1 
protein levels and reduced the infection of HeLa, diploid human WI-38 fibroblasts and 
human epithelial lung carcinoma A549 cells with AdV-C5-E1A-FS2A-GFP (AdV-C5-GFP), 
whereas non-targeting control siRNAs (siNT) had no effect (Fig. 1C-E). AdV-C5-GFP 
expressed stand-alone GFP from the immediate early viral E1A-GFP hybrid mRNA with a 
‘ribosome-skipping’ F2A sequence (Minskaia et al., 2013), placed between the E1A and 
GFP open reading frames. We observed strong infection inhibition and loss of Mib1 in 
polyclonal CRISPR/Cas9 Mib1 knock-out (KO) HeLa and A549 cells edited with a guide 
RNA directed to the first Mib1 exon, but not a non-targeting control guide RNA (sgNT) 
(Supplemental Fig. 1C-D). The dramatic block of AdV-C5 infection was confirmed in a 
monoclonal HeLa-sgMib1 line (clone 1), which had an insertion of a thymidine at position 
62 in all the Mib1 alleles. The HeLa-ATCC cells have three Mib1 genes (Adey et al., 2013). 
The insertion of a thymidine gave rise to a translational stop codon TGA, 186 nucleotides 
downstream of the insertion, and complete resistance to AdV-C5 infection, as indicated by 
the lack of the immediate early viral protein E1A (Supplemental Fig. 1E-F). Clone 1 was 
also resistant to AdV species A, B and D, but remained susceptible to herpes simplex virus 
1 (HSV-1), pseudotyped lentivirus, vesicular stomatitis virus (VSV), and influenza A virus 
(IAV) infections (Fig. 1F, Supplemental Fig. 1G). Mib1 KO cells even enhanced the 
infection with the RNA viruses IAV and VSV, possibly due to reduced anti-viral activity in 
Mib1 KO cells (Li et al., 2011). Regardless, the ectopic expression of Mib1 by a lentivirus 
in the Mib1-KO cells completely restored both AdV-C5 infection and Mib1 expression (Fig. 
1G-H).  
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Loss of Mib1 arrests incoming AdV at the NPC and blocks vDNA uncoating 
AdV enters cells by receptor mediated endocytosis, followed by penetration of the 
endosome, cytoplasmic transport, docking to the NPC and release of the genome into the 
nucleus (Fig. 2A, and Greber and Flatt, 2019). Microscopic analyses of single virions in 
single cells showed no reduction in AdV-C5 binding or endocytosis into cells treated with 
Mib1 siRNA or siNT, nor the exposure of the membrane lytic protein VI, or nuclear 
targeting (Fig. 2B-E, Supplemental Fig. 2A-D). Remarkably though, sgMib1 cells appeared 
to contain more virions at the nucleus 5 and 8 h pi, suggesting that Mib1 was involved in 
turning over intracellular AdV particles. During AdV uncoating in unperturbed cells, AdV 
capsid fragments are displaced from the NPC to the cell periphery (Strunze et al., 2011). 
Electron microscopy up to 7 h pi indicated no reduction of incoming AdV-C5 at the nuclear 
membrane in sgMib1 cells, unlike control cells, which showed a strong decline in virions 
compared to 1 h pi (Fig. 3A-B). This suggested a stable interaction of virions with NPCs in 
the absence of Mib1. This notion was supported by the finding that in Mib1-depleted cells, 
more virions colocalized with NPCs 8 h pi than in control cells, as indicated by single 
section super-resolution STED microscopy (Supplemental Fig. 3A-C). It is of note that 
several capsid puncta did not perfectly colocalize with the anti-NPC antibody Mab414, 
which reacts with the central transporter protein p62, the cytoplasmic filaments and the 
nuclear basket structures (Walther et al., 2001). Imperfect colocalization of AdV with 
Mab414 may reflect a heterogeneity of virion docking at NPCs (Cassany et al., 2015; 
Strunze et al., 2011; Trotman et al., 2001), or local curvature of the nuclear membrane. 
The latter gives rise to lateral rather than ‘on face’ views of AdV-NPC contacts, a 
phenomenon, which is observed in the superresolved confocal images at the nuclear edge 
(Supplemental Fig. 3A). Regardless, our analyses of single confocal mid-sections 
unequivocally showed strong colocalization of viral DNA with the capsids at the nuclear 
membrane of sgMib1 cells, and no evidence of vDNA in the nucleus, unlike control cells 
showing capsid-free viral genomes inside the nucleus, as delimited by lamin staining 
(Supplemental Fig. 3D).  
Next, we probed the genome contents of these particles using click chemistry, N3-
AlexaFluor 488 and confocal microscopy. Analyses of thousands of 5-ethynyl-2’-
deoxycytidine (EdC)-labeled viral genomes confirmed the virtual absence of vDNA 
separation from the capsids up to 5.5 h pi (Fig. 3C). Maximum image projections showed 
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that nearly all the virions of control cells released their genome either into the nucleus or 
misdelivered it to the cytosol (Fig. 3D). Mib1 depleted cells, however, showed almost no 
free viral genomes in the nucleus or the cytoplasm, but contained abundant amounts of 
EdC genome-positive virions, stained by the azide-containing fluorophore probe and 
contained in the leaky capsid. Such capsids are partly dismantled particles (Wang et al., 
2013), and were readily detected in the cytosol of both control and Mib1-lacking cells 30 
min pi (Fig. 3C-D). The data demonstrate that the release of vDNA from capsid and vDNA 
nuclear import are dramatically impaired in the absence of Mib1.  
The Ub ligase activity of Mib1 is required to reverse the AdV uncoating defect 
Mib1 is an E3 Ub ligase with three main domains, an N-terminal region comprising Mib-
Herc2 domains with a ZZ zinc finger, a middle region containing nine ankyrin repeats, and 
a C-terminal region containing three RING domains (Fig. 4A). While the N-terminal region 
mediates protein-protein interactions (Mertz et al., 2015), the C-terminal RING domain has 
E3 Ub ligase activity. We expressed various flag-tagged truncation mutants as well as two 
point mutants of Mib1 in sgMib1 cells by lentiviral transduction. While AdV-C5-GFP 
infection was completely restored by expression of full length Mib1, none of the truncation 
mutants rescued the infection, suggesting that both the N-terminal and C-terminal domains 
are required for AdV infection (Fig. 4B-C). Expression of a full length serine 805 to alanine 
(S805A) mutant abrogating phosphorylation at this position (Berndt et al., 2011; Ossipova 
et al., 2009) gave good rescue of infection. This stood in contrast to the substitution of 
cysteine 995 by serine (C995S), which did not rescue infection. The C995S mutant lacks 
ubiquitination activity due to a disrupted structure of the third RING domain (Berndt et al., 
2011; Itoh et al., 2003). Staining of incoming vDNA confirmed that the truncation mutant 
222-1006 and the C995S mutant failed to induce the genome release from the particles, 
unlike full length Mib1 (Supplemental Fig. 4).  
Mib1 localizes to microtubules in centriolar satellites near the microtubule organizing 
center (MTOC). AdV traffics on microtubules to the vicinity of the nuclear envelope where 
it detaches from microtubules and binds to NPCs (Strunze et al., 2005; Wang et al., 2017). 
To distinguish if Mib1 acted on the capsid in transit from the MTOC to the NPC, or directly 
at the NPC-docked capsid, we infected HeLa-sgMib1 cells containing a tetracycline-
inducible GFP-tagged Mib1. Upon virus internalization and arrest at the NPC, we added 
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doxycycline to induce the expression of GFP-Mib1, and analyzed the infected cells for 
vDNA uncoating. GFP-Mib1 expression was detectable as early as 1 h post induction, and 
led to the release of the vDNA from nearly all the capsids within 3 h of doxycycline 
treatment (Fig. 4D). By contrast, in cells that did not express GFP-Mib1, the vDNA 
remained confined inside the capsids.  
This result suggests that Mib1 performs a ubiquitination reaction directly at the site where 
the capsids are docked at NPCs. This notion was supported by live cell imaging of 
atto565-labeled AdV-C5 particles in GFP-Mib1 expressing HeLa-sgMib1 cells, 
demonstrating that as early as 60 min post doxycycline addition, Mib1 puncta overlapped 
with viral capsids in the nuclear vicinity (Supplemental Movie 1). The interactions of GFP-
Mib1 with the NPC-docked virions were transient, suggesting that Mib1 acts as a licensing 
factor on a cellular and/or a virion protein leading to vDNA uncoating. Remarkably, the 
expression pattern and dynamics of Mib1-GFP in uninfected cells showed rapid, linear and 
long-ranged trafficking of GFP-puncta, indistinguishable from infected cells (Supplemental 
Movie 2). We speculate that the Mib1 ubiquitination activity primes a cellular and/or virion 
protein for dissociation from the virion, and thereby unleashes the capsid disassembly 
reaction. Alternatively, the ubiquitylation of a cellular inhibitor of the AdV uncoating 
reaction at the NPC could initiate the release of a break in virion uncoating. Regardless, 
the absence of Mib1 caused a very strong and highly specific entry phenotype at the NPC, 
comparable perhaps to temperature-sensitive virus mutants, such as the endosomal 
escape-defective AdV-C2-TS1 (Imelli et al., 2009), or the HSV-1 mutants defective in 
uncoating at the NPC (Huffman et al., 2017; Knipe et al., 1981). These AdV and HSV-1 
mutants have pleiotropic defects in the virion due to lack of proteolytic maturation (Imelli et 
al., 2009; Jovasevic et al., 2008).  
Mib1 is abundantly available in most organs (Schmidt et al., 2018), and also in 
professional antigen-presenting cells, such as macrophages, which are infected by AdV (Li 
et al., 2011; Stichling et al., 2018). Besides being involved in Notch/Delta signalling (Itoh et 
al., 2003), Mib1 is implicated in centriole biogenesis (Cajanek et al., 2015), cell migration 
(Mizoguchi et al., 2017) and ciliogenesis (Wang et al., 2016), underscoring an important 
role in development (Koo et al., 2005). Point mutations in Mib1 can manifest in an 
autosomal-dominant fashion and cause disease, such as left ventricular noncompaction, 
the third most common cardiomyopathy (Luxan et al., 2013). In differentiated somatic cells, 
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however, Mib1 offers a novel anti-viral host target, for example in the lung, liver, gastro-
intestinal tract, or eye. Since Mib1 is highly conserved, with homology >95% in most 
mammals, and >91% in distant vertebrates such as Zebrafish (Apweiler et al., 2004), it 
may also support AdV infection in other species than homo sapiens. In sum, our study 
identifies an ‘on demand’ tunable mechanism for the delivery of vDNA into the nucleus and 
misdelivery to the cytoplasm (Fig. 4E). The ubiquitination activity of Mib1 licenses AdV 
uncoating at the NPC. Targeted perturbations of host functions can now be applied to 
explore the uncoating mechanism of the vDNA.  
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Figures and Legends 
Fig. 1: Mib1 is an essential host factor for AdV infection. 
(A) Overview of the experimental workflow of the genome-wide siRNA screen in HeLa 
cells.  
(B) The infection Z-scores from the genome-wide screen are plotted per gene in ascending 
order. The Z-score of Mib1 is indicated. See also Supplemental Tables 1, 2, 3. 
(C) A549 cells transfected with siRNAs against GFP, Mib1 or a non-targeting control were 
infected with AdV-C5-GFP at MOI 0.3 for 24 h. Nuclei were stained with DAPI, cells 
analyzed by fluorescence microscopy, and infection scored by measuring the GFP signal 
over the nuclei. The mean ± s.d. is shown (n = 3 replicates). Statistical significance was 
assessed using one-way ANOVA with Holm-Sidak correction for multiple comparisons. 
(D) A549 cells transfected with siRNAs were lysed at 48 h post transfection. Proteins were 
separated by SDS-PAGE and probed for Mib1 or GAPDH by Western blotting.  
(E) A549, HeLa, or WI-38 cells were transfected with siRNAs and infected with AdV-C5-
GFP as in (C). n = 3 biologically independent experiments. The P value was determined 
using an unpaired t-test. 
(F) Monoclonal HeLa-sgMib1 cells or control HeLa-sgNT cells were infected with different 
wild-type AdVs for 24 h. After fixation, cells were stained with a pan-hexon antibody and 
DAPI. Infection was scored by percentage of hexon-positive nuclei. Representative images 
shown. Scale bar, 100 µm. n = 3 biologically independent experiments. The P values were 
assessed using unpaired t-tests. 
(G) HeLa-sgNT or HeLa-sgMib1 cells were transduced with an empty lentivirus or 
lentivirus encoding Mib1. At 48 h post transduction, cells were infected with AdV-C5-wt, 
fixed at 24 h pi, and stained for the viral protein VI and DAPI. Infection was scored by 
percentage of protein VI-positive nuclei. Scale bar, 100 µm. n = 3 biologically independent 
experiments. Statistical significance was assessed using a one-way ANOVA with Holm-
Sidak correction. ***, p<0.0001. 
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(H) HeLa-sgNT or HeLa-sgMib1 cells were transduced with an empty lentivirus or 
lentivirus encoding Mib1, lysed 48 h post transduction, and processed as in (D). All bar 
graphs show the mean ± s.d. 
 
Fig. 2: Mib1 depletion does not affect the early steps of viral entry. 
(A) AdV-C5 entry schematic. 
(B) AdV-C5 was bound to siRNA-treated HeLa cells for 1 h on ice. The virus inoculum was 
removed and cells were fixed, followed by immunostaining of hexon, DAPI staining, 
AlexaFluor 647-conjugated succinimidyl ester (cell contents) and imaging by confocal 
microscopy. Data from one representative experiment is shown. n = 3 independent 
experiments gave similar results. P value was determined using a Mann-Whitney test. 
(C) AlexaFluor 488-labeled AdV-C5 was bound to siRNA-treated HeLa cells for 1 h on ice. 
Unbound virus was washed away, and bound virus internalized for 0, 10, or 20 min at 
37°C. Cells were treated with anti-hexon antibody for 1 h, fixed, permeabilized, and 
stained with secondary antibody, DAPI, and analyzed by confocal microscopy. Only virus 
particles on the cell surface are positive for anti-hexon. Representative data from one of n 
= 3 independent experiments is shown. P values were determined using a non-parametric 
ANOVA (Kruskal-Wallis test) with Dunn’s correction for multiple comparisons. 
(D) siRNA-treated HeLa cells were infected as in (C), fixed, and processed for 
immunostaining with anti-protein VI and DAPI. Representative data from one of n = 3 
independent experiments. P values were assessed using a Kruskal-Wallis test with Dunn’s 
correction. 
(E) AdV-C5 was bound to A549-sgNT or A549-sgMib1 cells for 1 h on ice. Unbound virus 
was washed away, cells fixed immediately (or after an additional 1, 3, 5 or 8 h of 
incubation at 37°C), processed for immunostaining with anti-hexon, DAPI, and 
succinimidyl ester, and imaged by confocal microscopy. Virus nuclear targeting was 
scored as percentage of capsids over the DAPI mask. n = 3 experiments gave similar 
results. P values were calculated using a Kruskal-Wallis test with Dunn’s correction. Mean 
± s.d. is shown for each graph. 
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Fig. 3: Genome release is impaired in Mib1-KO cells. 
(A) HeLa-sgNT and HeLa-sgMib1 cells were incubated with AdV-C5 at 37°C for 1 h. 
Unbound virus was washed away and cells returned to 37°C, fixed at 1, 2, or 5 h pi and 
processed for thin-slice transmission electron microscopy. Viral capsids near the nuclear 
envelope were counted and plotted. Data from one of n = 2 independent experiments is 
shown. P values were determined using a Kruskal-Wallis test with Dunn’s correction. 
(B) HeLa-sgNT and HeLa-sgMib1 cells were infected as in (A), fixed at 7 h pi, and 
processed for electron microscopy. Representative images of NPCs from slices of different 
cells are shown. Almost no viral particles were found in the sgNT cells. Two independent 
experiments yielded similar results. Scale bar, 100 nm. n, nucleus; c, cytoplasm. 
(C) HeLa-sgNT or HeLa-sgMib1 cells were incubated with genome-labeled AdV-C5-EdC 
for 1 h on ice, washed, transferred to 37°C, and fixed at the indicated timepoints. Capsids 
were stained with anti-hexon, and viral genomes visualized by click chemistry with an N3-
AlexaFluor 488. Nuclei were stained with DAPI and cell outlines with AlexaFluor 647-
conjugated succinimidyl ester, and cells analyzed by confocal microscopy. Incoming viral 
genomes were segmented and their corresponding hexon intensity plotted. Each dot 
represents one viral genome. Data collected in one of n = 3 independent experiments is 
shown. P values were assessed using a Kruskal-Wallis test with Dunn’s correction. Error 
bars depict the mean ± s.d.. 
(D) Representative images from the dataset collected in (C). Arrows show free cytoplasmic 
genomes, arrowheads depict nuclear genomes. Scale bar, 10 µm. n = 3 independent 
experiments gave similar results. Images are maximum projections.  
 
 
Fig. 4: Mib1 ubiquitination activity is required for AdV genome release. 
(A) Schematic representation of Mib1 domains.  
(B) HeLa-sgMib1 cells were transduced with lentivirus expressing the indicated constructs. 
Non-transduced HeLa-sgNT cells were included as a control. 48 h post transduction, cells 
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were infected with AdV-C5-GFP. At 24 h pi, cells were fixed, and nuclei stained with DAPI 
before imaging by fluorescence microscopy. Infection was scored by measuring GFP 
intensity over nuclei. Error bars depict the mean ± s.d. of three replicates in one 
representative of n = 3 independent experiments. Statistical significance was assessed by 
using a one-way ANOVA with Holm-Sidak correction for multiple comparisons. ***, 
p<0.0001.  
(C) HeLa-sgMib1 cells were transduced as in (B) and subsequently lysed and processed 
for SDS-PAGE and Western blotting. Expression of flag-Mib1 mutants was probed with an 
anti-flag antibody, flag-Cas9 served as a loading control. 
(D) HeLa-sgMib1 cells carrying a tetracycline-inducible GFP-Mib1 cassette were incubated 
for 1 h with AdV-C5-EdC. Unbound virus was washed away and internalized virus capsids 
were allowed to reach the nucleus for another 2 h. GFP-Mib1 expression was 
subsequently induced with 1 µg/ml doxycycline for 1 or 3 h, after which cells were fixed, 
stained for vDNA, hexon, and nuclei, and imaged via confocal fluorescence microscopy. 
Images are maximum projections. n = 3 independent experiments gave similar results. 
Scale bar, 10 µm. See also Supplemental Fig. 4. 
(E) Schematic model depicting the block in AdV DNA uncoating at the nuclear pore 
complex (NPC) in the absence of Mib1. Induced expression of the E3 ubiquitin (Ub) ligase 
Mib1 licenses AdV uncoating, vDNA nuclear import and misdelivery, and leads to infection.  
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STAR Methods 
 
LEAD CONTACT AND MATERIALS AVAILABILITY 
Further information and requests for resources and reagents should be directed to and will 
be fulfilled by the Lead Contact, Professor Urs Greber (urs.greber@imls.uzh.ch). All 
reagents generated in this study are available from the Lead Contact with a completed 
Materials Transfer Agreement. 
 
EXPERIMENTAL MODEL AND SUBJECT DETAILS 
Virus construction and growth 
All AdVs were grown in human A549 or HeLa-ATCC cells and purified over two cesium 
chloride gradients as previously described (Greber et al., 1996; Greber et al., 1993). AdV-
C5 (wt300) has been previously described (Hearing and Shenk, 1983). AdV-C5-E1A-
FS2A-GFP was constructed by inserting an enhanced GFP (GFP) cassette at the end of 
the E1A gene along with a furin cleavage site (FS) and a ‘ribosome-skipping’ F2A 
sequence derived from foot and mouth disease virus (Minskaia et al., 2013; Pacesa et al., 
2017; Robinson et al., 2009), leading to expression of stand-alone GFP under the E1A 
promoter. This is akin to a mouse AdV-1 expressing murine granulocyte-macrophage 
colony-stimulating factor and human AdV-B3 expressing a GFP reporter (Pacesa et al., 
2017; Robinson et al., 2009). AdV-C2-ΔE3B-CMV-GFP has been previously described and 
contains a GFP cassette under a CMV promoter in place of the non-essential E3B gene 
region (Yakimovich et al., 2012). Genome-labeled AdV-C5-EdC was produced by growing 
the virus in A549 cells in the presence of 2.5 µM EdC (5-Ethynyl-2′-deoxycytidine, Jena 
Biosciences) as described (Wang et al., 2013). Capsid-labeled AdV-C5-atto565 and AdV-
C5-AlexaFluor 488 were generated as previously described (Burckhardt et al., 2011; 
Greber et al., 1998). A GFP-expressing VSV-G pseudotyped lentivirus (LV-GFP) was 
constructed by cloning a GFP cassette into the multiple cloning site of the lentiviral vector 
pLVX-IRES-puro (Clontech). The lentivirus was then rescued as described below. GFP-
expressing vesicular stomatitis virus (VSV-GFP) was kindly provided by Y. Yamauchi 
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(University of Bristol) (Hayer et al., 2010). Influenza A virus strain X31 (H3N2) was 
purchased from Virapur. GFP-expressing HSV-1 strain C12 was kindly provided by S. 
Efstathiou (University of Cambridge)(Glauser et al., 2010). 
Generation of lentiviral particles 
4.5x106 HEK293T cells were seeded on a 10 cm dish. The next day, the cells were 
transfected with 3.4 µg pVSV-G (Clontech), 6.5 µg pCMV-dR8.91-Gag-Pol (kindly 
provided by J. Pavlovic, University of Zurich), and 10 µg of lentiviral expression plasmid 
using the calcium phosphate method. The culture supernatant was changed to fresh 
medium the following morning, and the supernatant containing the lentiviral particles was 
harvested at 2 days post transfection and filtered through a 0.45 µm filter before storage at 
-80°C. For experiments, cells were transduced with the lentiviral vectors at a MOI of 0.5 
and selected with 2 µg/ml puromycin or 10 µg/ml blasticidin. 
Reagents 
Anti-AdV pan-hexon (mouse, MAB8052) and anti-E1A (mouse, 05-599) were purchased 
from Millipore. Anti-Mib1 (rabbit, ab124929) and anti-NPC Mab414 (mouse, ab24609) 
were purchased from abcam. Anti-GAPDH (mouse, MA5-15738), anti-flag (mouse, MA5-
91878), and all secondary antibodies used for immunofluorescence were purchased from 
Thermo Fisher Scientific. Polyclonal anti-flag (rabbit, F7425) was purchased from Sigma-
Aldrich. All HRP-conjugated secondary antibodies used for Western Blotting were 
purchased from Cell Signaling Technologies. Rabbit polyclonal anti-AdV protein VI has 
been previously characterized (Burckhardt et al., 2011). Mouse monoclonal anti-AdV 
hexon 9C12 antibody was produced from hybridoma cell lines(Varghese et al., 2004). 
Mouse monoclonal anti-IAV NP antibody (HB-65) was a kind gift from Y. Yamauchi 
(University of Bristol). Lipofectamine RNAiMAX (13778075), Alexa Fluor 647 NHS Ester 
(A37566), Alexa Fluor 488 Azide (A10266), and Alexa Fluor 594 Azide (A10270) were 
purchased from Thermo Fisher Scientific. THPTA (762342), aminoguanidine hydrochloride 
(396494), copper sulfate (61230), and (+)-sodium L-ascorbate (11140) were purchased 
from Sigma-Aldrich. Doxycycline (631311) was purchased from Clontech.  
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METHOD DETAILS 
Cell cultures 
HEK293T, HeLa, A549, and WI-38 cells were maintained in Dulbecco’s Modified Eagle’s 
Medium (Gibco). Medium was supplemented with non-essential amino acids (Thermo 
Fisher) and 10% fetal calf serum (Gibco). During infection experiments, the medium was 
additionally supplemented with 100 U/ml penicillin and 100 µg/ml streptomycin. The cells 
were grown at 37°C in a 5% CO2 atmosphere for no longer than 20 passages.  
Genome-wide siRNA screen 
The RNA interference screen was performed as part of the InfectX consortium using a 
commercially available pooled genome-wide siRNA library from Dharmacon (Ramo et al., 
2014). The screen was conducted in HeLa CCL-2 cells in a 384-well plate format in two 
biological replicates. In each experiment, 25 µl of RNAiMAX (Invitrogen)/DMEM (0.1 µl / 
24.9 µl) mixture was added to each well of the screening plates containing 1.6 pmol siRNA 
diluted in 5 µl RNase-free ddH2O, after which the plates were incubated at room 
temperature (RT) for 1 h. Seven hundred HeLa cells were add per well in a volume of 50 µl 
DMEM/10% FCS, resulting in a final concentration of 6.7% FCS. Plates were incubated at 
37°C and 5% CO2 for 72 h prior to infection. All liquid handling stages of infection, fixation, 
and immunofluorescence (IF) staining were performed on the automated pipetting system 
Well Mate (Thermo Scientific Matrix) and washer Hydrospeed (Tecan). AdV-C2-ΔE3B-
GFP was added to the cells at a MOI of 0.1 in 10 µl of infection media (DMEM 
supplemented with L-glutamine, 10% FCS, 1% Pen/Strep, Invitrogen). The cells were 
incubated at 37°C for 16 h and then fixed by adding 21 µl of 16% PFA directly to the 
culture supernatant for 45 min at RT or long-term storage at 4°C. Cells were washed 2 
times with PBS containing 25 mM NH4Cl and permeabilized with 25 µl 0.1% Triton X-100 
(Sigma-Aldrich). After two washes with PBS the samples were incubated at RT for 1 h with 
25 µl PBS containing DAPI (1 µg/ml, Sigma-Aldrich) and DY-647-phalloidin (0.4 U/ml, 
Dyomics), washed 3 times with PBS and stored until imaging in 50 µl PBS supplemented 
with NaN3. Microscopy was performed with Molecular Devices ImageXpress microscopes. 
Nine sites per well in a 3x3 grid were imaged with a 10x S Fluor objective with 0.45 
numerical aperature (NA) in a 12-bit dynamic range. Infection was scored by quantifying 
the GFP intensity over segmented nuclei (based on DAPI staining) and cell bodies (based 
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on actin staining) using CellProfiler. All data generated during the screen including raw and 
processed images were shared through the openBIS system (Bauch et al., 2011). For the 
identification of pro-viral candidates, genes known to be involved in transcription and 
translation (such as polymerases, transcription factors, ribosomal proteins) were excluded 
based on their gene ontology terms. siRNAs that led to a strong reduction of cell numbers 
in the screen were additionally excluded in the validation experiments.  
String analysis 
Gene Ontology (GO) enrichment analysis of the strongest 500 infection up- and 
downregulating hits was performed with the “cellular components enrichment” tool of the 
STRING database (http://string-db.org). Statistical significance for enrichment by genome-
wide false discovery rate (FDR) was calculated using the STRING database (Szklarczyk et 
al., 2017). 
Generation of CRISPR/Cas9 KO cell lines 
For the generation of CRISPR/Cas9 knockout cells, we used a modified plasmid termed 
Lenti-eCas9. This plasmid was generated by replacing the Cas9 cassette from the 
lentiCRISPR v2 plasmid (Addgene #52961) (Sanjana et al., 2014) with the high-fidelity 
eCas9 from the eSpCas9(1.1) plasmid (Addgene #71814) (Slaymaker et al., 2016) by 
restriction cloning using XbaI and BamHI restriction sites. The sequences used as gRNA 
templates were 5’-GTTGGCGCTCGGGTAGTGCG-3’ for Mib1 and 5’-
(G)ACGGAGGCTAAGCGTCGCAA-3’ for a non-targeting gRNA, where the (G) denotes a 
nucleotide added for robust transcription from the U6 promoter. The sequences were 
cloned into the BsmBI site according to the instructions of the Zhang lab (Sanjana et al., 
2014). All plasmids were verified by Sanger sequencing. The plasmids were then used for 
the generation of lentiviral particles. HeLa and A549 cells were transduced with lentiviral 
supernatant. After two days, the cells were selected with 2 µg/ml puromycin until all non-
transduced cells were dead (ca. 5 days). Surviving cells from wells in which at least 50% 
of the cells had died were then expanded and frozen down. HeLa-sgMib1 cells were 
furthermore subcloned by limiting dilution. Unless otherwise stated, all experiments were 
performed with HeLa-sgMib1 cells grown from a single clone (cl. 1). 
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For sequencing analysis of the genome-edited cells, HeLa-ATCC and HeLa-sgMib1 cells 
were each grown in a 10 cm dish. When they reached 90% confluence, cells were lysed in 
lysis buffer (20 mM Tris pH 8.0, 20 mM NaCl, 4 mM EDTA, 1% SDS) and sheared through 
a 22G needle. Proteins were digested by incubation with 450 µg proteinase K for 2 h at 
55°C under agitation. RNA was digested by incubation with 200 µg RNase A for 1 h at 
37°C. DNA was then isolated through two repeated phenol-chloroform extractions with a 
phenol:chloroform:isoamyl alcohol solution at ratios of 25:24:1, pH 8, and precipitated by 
addition of 1/10 the volume of 3M potassium acetate pH 5.2 and 2 volumes of EtOH 
followed by incubation at -20°C overnight. After washing with 70% EtOH, DNA pellets were 
resuspended in TE buffer (pH 8) and used for PCR amplification of a 300 bp stretch 
surrounding the Cas9 cut site on the Mib1 ORF using GoTaq polymerase (Promega) with 
the following two primers carrying an XhoI or an EcoRI restriction site at their 5’ ends: 5’-
TTGCTCCTCGAGCTATGAGTAACTCCCGGAATAAC-3’ and 5’-
AAAGGAGAATTCTCTCCATGATAACACACTGTG-3’. The resulting PCR product was 
then gel-purified and ligated into a XhoI/EcoRI-digested pBluescript vector, which was then 
transformed into DH5α bacteria. The following day, more than 25 colonies were picked, 
their plasmid DNA isolated, and the PCR insert was sequenced by Sanger sequencing. 
Every colony from the sgMib1 sample showed the insertion of a single thymidine. To 
corroborate this result, we sent the PCR product for sequencing without prior 
transformation to analyze the amplified DNA from all Mib1 alleles. We analyzed the 
sequences using the TIDE web tool (https://tide.deskgen.com/), which allows quantitative 
assessment of genome editing by sequence trace decomposition (Brinkman et al., 2014). 
This analysis showed that 98.2% of reads from the HeLa-sgMib1 cells contained the 
insertion of a single T, confirming that all alleles carried the same frame-shift mutation. 
This is not surprising as the inDelphi tool (https://indelphi.giffordlab.mit.edu) which predicts 
the outcome of CRISPR/Cas9-mediated gene editing based on the gRNA target sequence 
context yields a high probability (>70% in human cancer cell lines) for a 1-bp insertion for 
this particular gRNA targeting site (Shen et al., 2018). A list of all used oligonucleotides is 
available in Supplemental Table 4.  
Construction of expression plasmids 
For constitutive expression, the lentiviral vector pLVX-IRES-puro (Clontech) was used. 
The Mib1 sequence was amplified by PCR from p3HA-hMib1 (Addgene #33317) with 5'-
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TAAGCAGAATTCATGAGTAACTCCCGGAATAACC-3' and 5'-
TGCTTAGCGGCCGCGGAATTCGCCCTTTCTTTAC-3' and cloned into the multiple 
cloning site (EcoRI/NotI) of pLVX-IRES-puro. To prevent cleavage of the re-introduced 
Mib1 gene by the Cas9/sgMib1 complex, the gRNA targeting site of Mib1 was mutated 
without changing the amino acid sequence via site-directed mutagenesis with the Q5 site-
directed mutagenesis kit (New England Biolabs) according to the manufacturer’s 
instructions with 5’-agttgtcagaGGCCCGGACTGGAAGTGG-3’ and 5’-
cttgcccctacCCCTTCCACCATCACCCG-3’. For detection of the Mib1 mutants, a flag-tag 
was introduced at the N-terminus of Mib1 using site-directed mutagenesis with 5’-
cgattacaaggatgacgatgacaagggtggaggcggttccAGTAACTCCCGGAATAAC-3’ and 5’-
atgtcatgatctttataatcaccgtcatggtctttgtagtcCATGAATTCACCGGAAATAG-3’. The Mib1 point 
and truncation mutants were constructed by site-directed mutagenesis with the primers in 
Supplemental list of oligonucleotides.  
For inducible expression, we first created a tetracycline-inducible lentiviral vector of the 
pLVX-IRES-puro backbone termed pLVX-tet-BSD which has been previously described 
(Roulin et al., 2018). pLVX-tet-BSD was constructed by replacing the CMV promoter, 
IRES, and puromycin resistance gene in pLVX-IRES-Puro with a tetracycline response 
element (TRE) followed by a multiple cloning site and an expression cassette containing a 
blasticidine deaminase (BSD), a P2A sequence, and a reverse Tet repressor (rTetR) 
under a constitutive EF-1α core promoter. GFP-Mib1 was constructed by insertion of Mib1 
from p3HA-hMib1 into the XhoI and EcoRI sites of pGFP-C1 using 5’-
TTGCTCCTCGAGCTATGAGTAACTCCCGGAATAAC-3’ and 5’-
TGGCAAGAATTCGGAATTCGCCCTTTCTTTAC-3’ as PCR primers. The GFP-Mib1 
sequence was then transferred from pGFP-Mib1 to pLVX-tet-BSD by restriction digest. 
pLVX-tet-BSD-GFP-Mib1 was then used to generate lentiviral particles for transduction of 
HeLa-sgMib1 cells. Transduced cells were selected with 10 µg/ml blasticidin for 7 days 
and then used for experiments or frozen down. 
SDS-PAGE 
Cells from a 24-well plate were washed with PBS, lysed in 200 µl SDS-PAGE lysis buffer 
(200 mM Tris pH 6.8, 10% glycerol, 5 mM EDTA, 0.02% bromphenol blue, 5% SDS, 50 
mM DTT) and boiled for 5 min at 95°C. Lysates were then loaded onto a SDS-PAGE gel 
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and transferred to a PVDF membrane (Amersham). After blocking with blocking solution 
(5% milk powder in 20 mM Tris, 150 mM NaCl, 0.1% Tween-20, pH 7.5), the membrane 
was incubated with primary and secondary antibodies diluted in blocking solution at 4°C 
overnight or 1h at RT, with 4 washes of TBST in between. HRP-coupled secondary 
antibody was detected using the ECL reagent (GE Healthcare). Primary antibodies were 
used at the following dilutions: anti-GAPDH 1:2500, anti-flag 1:1000, anti-Mib1 1:1000, 
anti-AdV E1A M73 1:500. Secondary antibodies used in Western blotting were goat anti-
rabbit-HRP (Cell Signaling, 7074) and goat anti-mouse-HRP (Cell Signaling, 7076) used at 
1:5000 dilution. 
siRNA transfections 
Two pmol siRNAs were diluted in a mixture of 9.85 µl Optimem and 0.15 µl RNAiMAX and 
spotted in a black 96-well plate (Greiner Bio-One). After 15 min incubation, 3000 cells 
were added per well in a volume of 90 µl DMEM supplemented with 10% FCS and 
nonessential amino acids (NEAA). The cells were typically incubated for 48 h before 
further treatment. The final siRNA concentration for all experiments was 20 nM. Unless 
stated otherwise, siMib1 #2 (Dharmacon) was used for depletion of Mib1 due to its strong 
knockdown efficiency. 
Infection  
Cells in a black 96-well imaging plate were ca. 50% confluent at the time of infection. The 
virus was diluted in infection medium (DMEM supplemented with 2% FCS, non-essential 
amino acids, pen/strep) to reach an infection of 20-60%. The culture supernatant was 
aspirated and 100 µl of infection mix was added to the cells. For all AdV and lentiviral 
infections, the cells were fixed at 24 h pi with 4% PFA. For infections with HSV-1, VSV, 
and IAV, the cells were fixed at 7 h pi. After fixation, remaining PFA was quenched with 25 
mM NH4Cl diluted in PBS for 5-10 min, followed by permeabilization with 0.5% Triton X-
100 in PBS for 3-5 min. If the virus carried a GFP transgene cassette, the cells were 
stained with DAPI at a concentration of 1 µg/ml in PBS for 3-5 min. For wild-type viruses, 
the cells were stained with the following primary antibodies diluted in blocking buffer (10% 
goat serum diluted in PBS) for 1 h at 4°C: mouse anti-hexon (Millipore, MAB8052) or rabbit 
anti-protein VI (Burckhardt et al., 2011) for AdV, and mouse anti-NP (ATCC, HB-65) for 
IAV. After three washes of 4 min each in PBS, the cells were stained with secondary 
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antibody (goat anti-rabbit-AlexaFluor 488 or goat anti-mouse-AlexaFluor 488, Thermo 
Fisher) diluted in blocking buffer containing 1 µg/ml DAPI for 30 min at RT. After three 
more washes of 4 min in PBS, the cells were imaged in a Molecular Devices high-
throughput microscope (IXM-XL or IXMc) in widefield mode with a 20x objective. For 
quantification of infection with CellProfiler (Carpenter et al., 2006), the nuclei were 
segmented according to the DAPI signal and the GFP intensity over the nuclear mask was 
measured. 
Endocytosis and protein VI exposure  
Forty thousand HeLa cells were reverse-transfected with 20 nM siNT (Dharmacon, Cat# 
D-001810-01-05)	or siMib1 (Dharmacon) onto a cover slip in a 24-well plate. At 2 days 
post transfection, the cells were incubated with atto565-labeled AdV-C5 (AdV-C5-atto565) 
diluted in cold binding medium (Hepes-buffered RPMI supplemented with 0.2% bovine 
serum albumin) for 1 h on ice. Unbound virus was washed away three times with PBS, 
fresh medium was added, and cells were moved to a 37°C water bath to allow 
internalization of viral particles for 0, 10, or 20 min. Cells were then inverted onto a 30 µl 
droplet of 9C12 anti-hexon antibody (Varghese et al., 2004) diluted in cold binding medium 
and placed on ice for 1 h. The cover slips were then transferred back into the wells, 
washed 3x with PBS, and fixed with 4% PFA for 15 min at RT. The samples were then 
quenched with 25 mM NH4Cl for 5-10 min and permeabilized with 0.5% Triton X-100 in 
PBS for 3-5 min at RT. For immunostaining, the coverslips were inverted onto a 30 µl 
droplet of antibody diluted in blocking buffer (10% goat serum in PBS) containing an 
affinity-purified rabbit anti-protein VI antibody (Suomalainen et al., 2013) at 4°C for 1 h. 
After three washes of PBS for 4 min each, the cells were incubated with the appropriate 
secondary antibodies and the nuclei were stained with DAPI. The samples were imaged 
on a Leica SP8 confocal laser scanning microscope (cLSM) with a 63x objective and a 
zoom factor of two. Z-stacks were acquired with intervals of 0.5 µm across the entire 
height of the cells. Sequential acquisition was between frames with line averaging 
(depending on the signal-to-noise ratio) at a scanning speed of 700 Hz. After recording the 
images, virus capsids were segmented using CellProfiler based on the atto565 signal. The 
signal from the hexon antibody determined whether the particle was outside or inside the 
plasma membrane. The signal from the protein VI antibody indicated successful exposure 
of protein VI, as the antibody cannot penetrate the virus capsids.  
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Virus binding  
Forty thousand HeLa cells were reverse-transfected with 20 nM siNT or siMib1 onto a 
cover slip in a 24-well plate. At 2 days post transfection, the cells were incubated with 
AdV-C5 diluted in cold binding medium on ice for 1 h. Subsequently, unbound virus was 
washed away with PBS and cells were fixed with 4% PFA. After fixation, remaining PFA 
was quenched and cells were permeabilized and stained with 9C12 anti-hexon antibody. 
Cell nuclei were stained with DAPI and cell outlines with AlexaFluor 647-conjugated 
succinimidyl ester. Cells were imaged on a Leica SP8 confocal microscope as described 
above. Nuclei were segmented based on the DAPI signal, cell outlines based on 
succinimidyl ester, and virus capsids based on the antibody signal. 
Nuclear targeting 
Eighty thousand A549-sgNT or A549-sgMib1cells were seeded on cover slips in a 24-well 
plate. The following day, cells were incubated with wt AdV-C5 in cold binding medium for 1 
h on ice. Unbound virus was washed away, and cells were either fixed with 4% PFA, or 
given fresh medium and placed in the incubator for 1, 3, 5, or 8 additional hours. After 
fixation, remaining PFA was quenched and cells were permeabilized and stained with 
9C12 anti-hexon antibody. Cell nuclei were stained with DAPI and cell outlines with 
succinimidyl ester. Cells were imaged on a Leica SP8 confocal microscope as described 
above. For determination of nuclear targeting efficiency of virus, nuclei were segmented 
based on the DAPI signal, cells based on the succinimidyl ester signal, and capsids based 
on the antibody signal in maximum projection images. The number of capsids over the 
nuclear mask was then set in relation to the number of capsids over the entire cell. 
Click chemistry and vDNA analysis 
Cells grown on cover slips were incubated with genome-labeled AdV-C5-EdC (Wang et 
al., 2013) for various time points. After fixation, quenching, and permeabilization, samples 
were stained for incoming capsids with the 9C12 anti-hexon antibody. After primary and 
secondary antibody incubation, the cover slips were inverted onto a 30 µl droplet of click 
reaction mix for 2 h at RT. The freshly prepared click reaction mix consisted of 10 µM 
AlexaFluor 594- or AlexaFluor 488-conjugated azide (Thermo Fisher Scientific), 1 mM 
CuSO4, and 10 mM sodium ascorbate in the presence of 1 mM THPTA and 10 mM 
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aminoguanidine (AG) in PBS. Samples were stained with DAPI and imaged with a Leica 
SP8 cLSM as described above. Single viral genomes and/or capsids were segmented 
according to the corresponding signal using CellProfiler. 
Expression of Mib1 and Mib1 mutants 
HeLa-sgMib1 cells were transduced with lentivirus containing expression cassettes of 
Mib1 or Mib1 mutants under a CMV promoter. Two days after transduction, the cells were 
infected with AdV-C5-GFP for 24h and the infection efficiency was quantified as described 
above. For the analysis of incoming vDNA, cells were incubated with AdV-C5-EdC for 1 h 
on ice followed by 3 h at 37°C. Cells were then processed for immunostaining and click 
chemistry. For analysis of Mib1 expression, cells were lysed in SDS-PAGE lysis buffer, 
and proteins were separated via SDS-PAGE, followed by Western blotting with rabbit anti-
flag antibody at 1:1000 dilution to detect the flag-Mib1 proteins.  
Doxycycline-induced expression of Mib1 
HeLa-sgMib1 cells which had been transduced with LVX-tet-BSD-GFP-Mib1 and selected 
for seven days with blasticidin were seeded on cover slips and infected with AdV-C5-EdC. 
After 1 h at 37°C, cells were washed and given fresh medium. The cells were placed back 
at 37°C for an additional 2 h to give the virus capsids enough time to traffic to the nucleus. 
Subsequently, GFP-Mib1 expression was induced with 1 µg/ml doxycycline. After 1 or 3 h, 
cells were fixed and processed for immunostaining against hexon and click chemistry. 
Samples were imaged on a Leica SP8 cLSM.  
Confocal microscopy 
A Leica SP8 cLSM was used in all experiments, in which single viral particles and 
genomes were imaged. Imaging was performed at a scanning speed of 700 Hz with a 63x 
magnification oil objective with a numerical aperture of 1.40 and a zoom factor of 2, with a 
pixel size of 0.181 µm. z-stacks were captured with a step size of 0.5 µm to capture the 
entire cell, and the size of the pinhole was 1 Airy unit. Leica hybrid detectors (HyD) were 
used for each channel. 
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gSTED microscopy 
Eighty thousand HeLa-sgNT or HeLa-sgMib1 cells were seeded on cover slips in a 24-well 
dish. The following day, cells were infected with 4 µg of AdV-C5-atto565. After 3 h, 
unbound virus was washed away and the cells were incubated in fresh medium for an 
additional 5 h. Cells were fixed, quenched, and permeabilized and subsequently stained 
with Mab414 antibody against nuclear pore complexes (1:100 dilution) and goat anti-
mouse-Abberior STAR 635P (1:100 dilution). The cover slips were mounted onto ProLong 
Gold Antifade Mountant (Thermo Fisher Scientific) and imaged the following day on a 
Leica SP8 inverse STED 3X microscope. Images were acquired with a 100x, 1.40NA 
objective with a pixel size of 14 nm and gating from 1.5 to 6 ns. A 660 nm depletion laser 
was used for the atto565 fluorophore, a 775 nm depletion laser was used for Abberior 
STAR 635P. Due to slight drift during image acquisition, CellProfiler was used to align 
STED images from each channel to their respective confocal images, which were taken 
without STED mode at the beginning of the image sequence. 
Confocal spinning-disc live microscopy 
Eight thousand HeLa-sgMib1 cells transduced with a doxycycline-inducible GFP-Mib1 
lentivirus were seeded in a 10-well CELLview slide (Greiner Bio-One) with a 175 µm thick 
cover glass embedded in its bottom. After two days, the cells were incubated with AdV-C5-
atto565 for 30 min at 37°C, or left uninfected. Unbound virus was washed away and the 
cells were incubated for another 60 min at 37°C so that most viral capsids would reach the 
nuclear envelope. Fresh medium without phenol-red containing 1 µg/ml doxycycline was 
added to the cells to induce expression of GFP-Mib1, and live imaging was started 1 h 
later on a Visitron CSU-W1 spinning disk microscope consisting of a Nikon Eclipse T1 
microscope and a Yokogawa confocal scanning unit W1 with a stage top incubation 
system at 37°C and 5% CO2. Z-stacks consisting of four steps with a step size of 1.4 µm 
were acquired every 30 s for ca. 120 min with a 100x oil objective (NA 1.4) and a pinhole 
of 50 µm. The focus was maintained with a perfect focus system (PFS). 
Transmission electron microscopy 
About 2.5x106 HeLa-sgNT or HeLa-sgMib1 cells were seeded in 10 cm dishes. The next 
day, they were infected with 325 µg wt AdV-C5. After 1h at 37°C, the virus inoculum was 
 38 
removed and the cells were fixed after 0, 1, 4, or 6 Mib1 of further incubation at 37°C. For 
fixation, cells were washed once with PBS-Ca2+/Mg2+(PBS supplemented with 0.5 mM 
MgCl2 and 1 mM CaCl2) and then scraped off into 5 ml PBS-Ca2+/Mg2+. Cells were 
pelleted by centrifugation at 500 x g for 4 min and resuspended in 750 µl of PBS-
Ca2+/Mg2+. 750 µl of fixative (4% glutaraldehyde in PBS-Ca2+/Mg2+) was then added to a 
final concentration of 2% glutaraldehyde. Cells were incubated for 30 min at RT under 
rotation, then pelleted (1200 xg for 5 min) and resuspended in 1 ml PBS-Ca2+/Mg2+. Cells 
were then pelleted and resuspended in 400 µl 2% agar noble (BD Biosciences) solution in 
PBS-Ca2+/Mg2+ and placed at 65°C for 5 min. Cells were centrifuged in a swing rotor at 
3000 xg for 5 min, yielding a cell pellet in solidified agar while the rest of the agar was 
discarded. The cell pellet was then incubated in a 1% reduced osmium tetroxide solution 
(freshly prepared from a 1:1 solution of 2% osmium tetroxide and 3% potassium 
ferricyanide) for 1 h on ice. Cells were then rinsed three times for 30 min in PBS-Ca2+/Mg2+ 
and 5 min in ddH2O, then pre-stained with a 2% uranyl acetate solution overnight at 4°C. 
For sample dehydration, the samples were successively incubated with 30% acetone for 5 
min, 50% acetone for 5 min, 70% acetone for 30 min, 90% acetone for 10 min, 100% 
acetone for 5 min and 100% acetone for 10 min. Samples were embedded in a 48% epoxy 
resin containing 16% dodecenyl succinic anhydride, 34% methyl nadic anhydride, and 2% 
benzyldimethylamine. The resin was allowed to polymerize at 60°C for 3 days. Ultrathin 
100 nm sections were obtained with a Leica Ultracut UCT ultramicrotome (Leica 
Microsystems) and mounted on copper grids with parlodion-carbon support film, placed 
sideways on a droplet of 2% uranyl acetate in H2O for 30 min, immersed repeatedly in 
H2O, dried overnight, placed on a droplet of Sato’s lead staining solution for 20 min, 
washed in H2O and then dried for 30 min. Samples were imaged in a FEI CM100 electron 
microscope at 80 kV. 
Image analysis 
Images were analyzed and quantified by using custom CellProfiler (version 2.1.1) and 
KNIME (version 2.12.2) pipelines. For infection assays, the nuclei were segmented using 
the DAPI channel, and the mean GFP intensity on the identified nuclei was measured. The 
GFP intensity threshold for infection was based on the non-infected controls. For 
quantification of single viral particles and genomes, maximum projections of the image 
stacks were used. Nuclei and cell outlines were segmented according to the DAPI and the 
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succinimidyl ester staining, respectively. In cases where no succinimidyl ester was 
included, the channel with the strongest cellular background was used for the cell 
segmentation. Viral particles and/or genomes inside the cell outlines were then segmented 
and the mean intensities of the other channels on these objects were reported. 
 
QUANTIFICATION AND STATISTICAL ANALYSIS 
Unless otherwise indicated, graphs display mean ± standard deviation (SD) and represent 
data from at least three independent experiments. All data was plotted and statistical 
analyses performed with GraphPad Prism 8.0 software (GraphPad). Significance indicated 
by asterisks is designated as follows: *, p<0.05; **, p<0.01; ***, p<0.001; ns, non-
significant. The following statistical tests were used: Unpaired (two-tailed) t-test, Figures 
1E-F; Ordinary one-way ANOVA with Holm-Sidak correction for multiple comparisons, 
Figures 1C, 1G, 4B; Mann-Whitney test, Fig. 2B; non-parametric ANOVA (Kruskal-Wallis 
test) with Dunn’s correction for multiple comparisons, Figures 2C, 2D, 2E, 3A, 3C. As 
indicated in the relevant figures, the term ‘n’ refers to the number of cells (Figures 2B-E, 
3A, supplemental figure 3B,C) or the number of viral particles (Figure 3C) used in the 
analysis. 
 
DATA AND CODE AVAILABILITY 
The data from the genome-wide RNAi screen are in Supplemental Table 1. The results of 
the gene ontology enrichment analyses are in Supplemental Tables 2 and 3. The code for 
the various scripts that were used to analyze the images are available by contacting the 
Lead Author. 
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KEY RESOURCES TABLE 
REAGENT or RESOURCE SOURCE IDENTIFIER 
Antibodies 
Rabbit polyclonal anti-Adenovirus protein VI (Burckhardt et al., 
2011) 
N/A 
Anti-Adenovirus antibody (anti-Hexon), Dil: 1:1000 Millipore Cat# MAB8052, 
RRID: AB_95243,  
Mouse anti-Hexon antibody 9C12 (Varghese et al., 
2004) 
N/A 
Mouse anti-E1A antibody M73, Dil: 1:500 Millipore Cat# 05-599, RRID: 
AB_309833 
Rabbit monoclonal anti-Mib1 antibody, Dil: 1:1000 Abcam Cat# ab124929, 
RRID: AB_11127834 
Mouse anti-GAPDH antibody, Dil: 1:2500 Thermo Fisher 
Scientific 
Cat# MA5-15738, 
RRID: AB_10977387 
Mouse monoclonal anti-flag antibody FG4R, Dil: 
1:1000 
Thermo Fisher 
Scientific 
Cat# MA5-91878, 
RRID: AB_1957945 
Rabbit polyclonal anti-flag antibody, Dil: 1:1000 Sigma-Aldrich Cat# F7425, RRID: 
AB_439687 
Mouse monoclonal anti-IAV NP antibody HB-65 ATCC, (Yamauchi et 
al., 2011) 
Cat# HB-65, RRID: 
CVCL_4524 
Mouse monoclonal Mab414, Dil: 1:500 Abcam Cat# ab24609, 
RRID: AB_448181 
Goat anti-Mouse IgG antibody, AlexaFluor 488, Dil: 
1:500 
Thermo Fisher 
Scientific 
Cat# A-11029, 
RRID: AB_138404 
Goat anti-Mouse IgG antibody, AlexaFluor 594, Dil: 
1:500 
Thermo Fisher 
Scientific 
Cat# A-11005, 
RRID: AB_141372 
Goat anti-Mouse IgG antibody, AlexaFluor 680, Dil: 
1:500 
Thermo Fisher 
Scientific 
Cat# A-21058, 
RRID: AB_2535724 
 41 
Goat anti-Rabbit IgG antibody, AlexaFluor 488, Dil: 
1:500 
Thermo Fisher 
Scientific 
Cat# A-11034, 
RRID: AB_2576217 
Goat anti-Rabbit IgG antibody, AlexaFluor 594, Dil: 
1:500 
Thermo Fisher 
Scientific 
Cat# A-11037, 
RRID: AB_2534095 
Goat anti-Rabbit IgG antibody, AlexaFluor 680, Dil: 
1:500 
Thermo Fisher 
Scientific 
Cat# A-21109, 
RRID: AB_2535758 
Goat anti-Mouse IgG antibody, HRP-linked, Dil: 
1:5000 
Cell Signaling Cat# 7076, RRID: 
AB_330924 
Goat anti-Rabbit IgG antibody, HRP-linked, Dil: 
1:5000 
Cell Signaling Cat# 7074, RRID: 
AB_2099233 
Bacterial and Virus Strains  
Competent cells DH5a strain  N/A 
AdV-C5 (wt300) (Hearing and Shenk, 
1983) 
N/A 
AdV-C5-GFP This paper N/A 
AdV-C5-EdC (genome-labeled) (Wang et al., 2013) N/A 
AdV-C5-atto565 (capsid-labeled) (Luisoni et al., 2015) N/A 
AdV-C2-dE3B-CMV-GFP (Yakimovich et al., 
2012) 
N/A 
AdV-A31 Anja Ehrhardt N/A 
AdV-B3  N/A 
AdV-D8  N/A 
Influenza A virus x31 (H3N2) Virapur, (Yamauchi et 
al., 2011) 
N/A 
HSV-1-GFP C12 (Glauser et al., 2010) N/A 
VSV-GFP (Hayer et al., 2010) N/A 
Chemicals, Peptides, and Recombinant Proteins 
DAPI (4',6-diamidino-2-phenylindole) Sigma-Aldrich Cat# D9542 
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Lipofectamine RNAiMAX Thermo Fisher 
Scientific 
Cat# 13778075 
Alexa Fluor 647 NHS Ester (Succinimidyl Ester) Thermo Fisher 
Scientific 
Cat# A37566 
Alexa Fluor 488 Azide, Triethylammonium Salt Thermo Fisher 
Scientific 
Cat# A10266 
Alexa Fluor 594 Azide, Triethylammonium Salt Thermo Fisher 
Scientific 
Cat# A10270 
THPTA (Tris(3-hydroxypropyltriazolylmethyl)amine) Sigma-Aldrich Cat# 762342 
AG (Aminoguanidine hydrochloride) Sigma-Aldrich Cat# 396494 
Copper sulfate Sigma-Aldrich Cat# 61230 
(+)-Sodium L-ascorbate Sigma-Aldrich Cat# 11140 
Doxycycline Clontech Cat# 631311 
ECL Prime Western Blotting Detection Reagent Amersham Cat# RPN2232 
Critical Commercial Assays 
Zyppy Plasmid Miniprep Kit Zymo Research Cat# D4036 
NucleoBond Xtra Midi Kit Macherey Nagel Cat# 740410.100 
Experimental Models: Cell Lines 
HeLa ATCC CCL-2, RRID: 
CVCL_0030 
HEK293T ATCC CRL-3216, RRID: 
CVCL_0063 
A549 ATCC CCL-185, RRID: 
CVCL_0023 
WI-38 ATCC CCL-75, RRID: 
CVCL_0579 
Oligonucleotides 
See Supplemental Table S4   
Recombinant DNA 
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lentiCRISPR v2 (Sanjana et al., 2014) Addgene #52961 
eSpCas9(1.1) (Slaymaker et al., 
2016) 
Addgene #71814 
Lenti-eCas9 This paper N/A 
Lenti-eCas9-sgMib1 This paper N/A 
Lenti-eCas9-sgNT This paper N/A 
pLVX-IRES-puro Clontech Cat# 632183 
pLVX-Mib1_res This paper N/A 
pLVX-flag-Mib1 This paper N/A 
pLVX-flag-Mib1-C995S This paper N/A 
pLVX-flag-Mib1-S805A This paper N/A 
pLVX-flag-Mib1-1-221 This paper N/A 
pLVX-flag-Mib1-1-818 This paper N/A 
pLVX-flag-Mib1-222-1006 This paper N/A 
pLVX-flag-Mib1-222-818 This paper N/A 
pCW57.1 David Root Addgene #41393 
pLVX-tet-BSD This paper N/A 
pEGFP-C1 Clontech Cat# 6084-1 
pEGFP-Mib1 This paper N/A 
pLVX-tet-BSD-EGFP-Mib1 This paper N/A 
pCMV-dR8.91-Gag-Pol Jovan Pavlovic 
(Crameri et al., 2018) 
N/A 
pVSV-G Clontech Cat# 631530 
p3HA-hMib1  Vanessa Redecke Addgene #33317 
Software and Algorithms 
GraphPad Prism version 8.0 GraphPad Software https://Mib1.graphpa
d.com/  
Fiji (Schindelin et al., 
2012) 
https://fiji.sc/#downlo
ad  
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Leica Application Suite LAS Leica https://Mib1.leica-
microsystems.com/p
roducts/microscope-
software/p/leica-las-
x-ls/ 
CellProfiler version 2.1.1 (Carpenter et al., 
2006) 
https://cellprofiler.org
/releases/  
KNIME version 2.12.2 KNIME https://Mib1.knime.c
om/downloads  
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Supplemental Items 
Supplemental Tables 
Supplemental Table 1: Infection indices and cell numbers of the genome-wide 
RNAi screen including Z-scores of HeLa cells infected with AdV-C2-
ΔE3B_GFP (related to Fig. 1). 
Table shows the gene identifiers, the gene names, the Z-scores for the infection indices 
and for the cell number for each replicate (rG1, rG2), and the averages of the two 
measurements. 
 
Supplemental Table 2: Gene ontology enrichment analysis of the top 500 
infection reducing hits (related to Fig. 1). 
Gene ontology (GO) enrichment analysis of the 500 candidates with the lowest infection Z-
scores from Supplemental Table 1 using the “cellular components enrichment” tool of the 
STRING database. The genes identified for each GO term are listed with their Ensembl 
protein identifiers and their gene names.   
 
Supplemental Table 3: Gene ontology enrichment analysis of the top 500 
infection enhancing hits (related to Fig. 1). 
Gene ontology (GO) enrichment analysis of the 500 candidates with the highest infection 
Z-scores from Supplemental Table 1 using the “cellular components enrichment” tool of 
the STRING database.  
 
Supplemental Table 4: List of oligonucleotides (related to STAR Methods). 
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Supplemental Movies 
Supplemental Movie 1: Transient colocalization of GFP-Mib1 with NPC-
docked fluorescent AdV-C5 increases the motility of the virions (related to 
Fig. 4). 
HeLa-sgMib1 cells containing a GFP-Mib1 cassette under a tetracycline-response element 
were incubated with atto565-labeled AdV-C5 for 90 min. Expression of GFP-Mib1 was 
then induced with 1 µg/ml doxycycline, and cells were imaged in a confocal spinning-disk 
microscope starting at 1 h post induction. Four z-slices were imaged at an interval of 30 s, 
of which one slice is shown. Green, GFP-Mib1; magenta, AdV-C5. Arrows indicate events 
of colocalization at the nuclear envelope. Time stamps indicate h:min:sec. Scale bar, 10 
µm. 
 
Supplemental Movie 2: Localization and movement of Mib1 puncta in non-
infected cells (related to Fig. 4). 
HeLa-sgMib1 cells containing a GFP-Mib1 gene expression cassette under a tetracycline-
response element were treated and imaged as in Supplemental Movie, except that they 
were not infected by AdV. There was no apparent difference in the localization or 
movement of the GFP-Mib1 puncta compared to the infected cells. 
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SUPPLEMENTAL MATERIALS 
 
The E3 Ubiquitin Ligase Mind Bomb 1 Controls Adenovirus Genome 
Release at the Nuclear Pore Complex 
M. Bauer, J.W. Flatt, D. Seiler, B. Cardel, M. Emmenlauer, K. Boucke, M. 
Suomalainen, S. Hemmi & U.F. Greber 
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Supplemental Fig. 1: Aggregated hits from the genome wide siRNA screen 
down- or up-regulating AdV infection and characterization of the 
CRISPR/Cas9 Mib1 KO cells (related to Fig. 1). 
(A) Gene ontology enrichment analysis was performed on the top 500 infection reducing 
siRNA hits using the “cellular components enrichment” tool of the STRING database.  
(B) Gene ontology enrichment analysis was performed on the top 500 infection enhancing 
siRNA hits as in Supplemental Fig. 1A.  
(C) A549 or HeLa cells were transduced with Lenti-eCas9-sgNT or Lenti-eCas9-sgMib1 at 
a MOI of 0.4. After two days, cells were selected for five days with 2 µg/ml puromycin. The 
polyclonal puromycin-resistant cell populations were then seeded in a 96-well plate and 
infected with AdV-C5-GFP for 24 h, after which cells were fixed and nuclei stained with 
DAPI. Cells were analyzed by fluorescence microscopy, and infection was quantified 
based on the GFP signal, normalized to the mean GFP signal in the sgNT control cells. 
Bar graphs show mean ± s.d. from n = 2 independent experiments. 
(D) The polyclonal populations described in Supplemental Fig. 1C were lysed and proteins 
were separated on an SDS-PAGE gel, followed by Western blotting. The membrane was 
probed with anti-Mib1 and anti-GAPDH antibodies. 
(E) Genomic DNA was isolated from HeLa-ATCC cells or from monoclonal HeLa-sgMib1 
cells (cl. 1). A 300 bp region containing the Mib1 sequence targeted by the guide RNA was 
amplified by PCR and cloned into the pBluescript vector, which was then used to transform 
bacteria. Plasmid DNA from more than 25 clones was isolated and sequenced using the 
Sanger method. All alleles carried the insertion of a single thymidine after Cas9-sgMib1 
treatment, as shown here. PAM (protospacer adjacent motif) of the gRNA is indicated. The 
Cas9 cuts three bp upstream of the PAM, which is where the extra thymidine was inserted 
upon DNA repair. 
(F) HeLa-sgNT or HeLa-sgMib1 cells were seeded in a 24-well plate and infected with 1 or 
5 µg of AdV-C5. At 6 h pi, cells were lysed, and proteins were separated via SDS-PAGE, 
followed by Western blotting. Membranes were probed with the indicated antibodies. 
(G) HeLa-sgNT or HeLa-sgMib1 cells were seeded in a 96-well plate and infected with 
GFP expressing HSV-1 (HSV-1-GFP), VSV-G pseudotyped lentivirus (Lenti-GFP), 
vesicular stomatitis virus (VSV-GFP). A549-sgNT and A549-sgMib1 cells were infected 
with the H3N2 influenza A virus strain x31 (IAV x31). All cells were fixed at 7 h pi, except 
for Lenti-GFP infected cells which were fixed at 24 h pi. IAV infection was visualized by 
immunostaining with anti-NP antibody (HB-65). Nuclei were stained with DAPI and cells 
were imaged by fluorescence microscopy. Infection was scored by percentage of protein 
GFP-positive nuclei or HB-65-positive nuclei in the case of IAV. Data from n = 3 
independent experiments is shown. All bar graphs in this figure depict mean ± s.d. 
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Supplemental Fig. 2: Fluorescence micrographs underlying analyses of AdV 
cell binding, endocytosis, exposure of the membrane-lytic protein VI and 
virion nuclear targeting (related to Fig. 2). 
(A-D) show representative maximum projection images of A549 cells corresponding to the 
Fig. 2 (B-E). Scale bars, 10 µm. 
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Supplemental Fig. 3: Enhanced colocalization of incoming AdV with the NPCs 
in Mib1 KO cells (related to Fig. 3).  
(A) HeLa-sgNT and HeLa-sgMib1 cells were seeded on cover slips in a 24-well plate. 
The following day cells were incubated with atto565-labeled AdV-C5. After 3 h at 37°C, 
unbound virus was washed away and cells were incubated for another 5 h, after which 
cells were fixed. Nuclear pore complexes were stained with the Mab414 antibody. Cells 
were imaged with a confocal gSTED super-resolution microscope. The images show the 
bottom of the nuclear membrane. Significantly more virus capsids are docked at NPCs in 
the sgMib1 cells than the control cells. Scale bars, 1 µm. 
(B) The NPCs were segmented and probed for AdV signal. Colocalization was assessed 
by thresholding of the AdV-atto565 intensity over each NPC. 
(C) AdV particles over the nuclear membrane were segmented and counted in each 
image.  
(D) HeLa-sgNT and HeLa-sgMib1 cells were infected with AdV-C5-EdC for 5 h, fixed, and 
stained for hexon, vDNA, and lamin. Image stacks were acquired across the entire 
nucleus. To distinguish nuclear from cytoplasmic vDNA, we analyzed single optical 
sections across the center of the nuclei where hexon was outside the nucleus. In sgNT 
cells, capsid-free vDNA can be seen inside the nucleus, whereas in sgMib1 cells most of 
the vDNA puncta colocalize with hexon at the nuclear membrane. Scale bar, 10 µm. 
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Supplemental Fig. 4: Single cell, single genome analyses of AdV DNA 
uncoating in sgMib1 cells expressing flag-tagged Mib1 constructs (related to 
Fig. 4). 
HeLa-sgMib1 cells were transduced with lentivirus for expression of the indicated 
constructs. After two days, cells were incubated with AdV-C5-EdC for 1 h on ice, after 
which unbound virus was washed away and infection was allowed to progress for 3 h. 
Cells were then fixed with 4% PFA and processed for immunostaining with anti-hexon and 
anti-Mib1 antibody, followed by click chemistry for incoming viral DNA and DAPI for nuclei. 
Cells were imaged with a confocal microscope. Genome release was only observed in 
cells expressing wild-type Mib1 or the S805A mutant. Shown are maximum projections of 
representative images. Scale bar, 10 µm. 
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Supplemental Table 4: List of oligonucleotides (related to STAR Methods). 
Oligonucleotide	
name	
Sequence	 Purpose	
siMib1	#1	 Dharmacon,	GACCUGAGCAUUCGAAAUA	 RNAi	
siMib1	#2	 Dharmacon,	GGUAUGCUCUGACAAGAAA	 RNAi	
siMib1	#3	 Dharmacon,	GUAAGAAACGUGAUGAUAU	 RNAi	
siMib1	#4	 Dharmacon,	CGAAGAGUGCCUUUCAUUA	 RNAi	
siNT	 (non-
targeting)	
Dharmacon,	Cat#	D-001810-01-05	 RNAi	
sgMib1_f	 caccGTTGGCGCTCGGGTAGTGCG	 CRISPR	
sgMib1_r	 aaacCGCACTACCCGAGCGCCAAC	 CRISPR	
sgNT_f	 caccgACGGAGGCTAAGCGTCGCAA	 CRISPR	
sgNT_r	 aaacTTGCGACGCTTAGCCTCCGTc	 CRISPR	
Mib1_EcoRI_f	 TAAGCAGAATTCATGAGTAACTCCCGGAATAACC	 Cloning	
Mib1_NotI_r	 TGCTTAGCGGCCGCGGAATTCGCCCTTTCTTTAC	 Cloning	
Mib1_XhoI_f	 TTGCTCCTCGAGCTATGAGTAACTCCCGGAATAAC	 Cloning	
Mib1_EcoRI_r	 TGGCAAGAATTCGGAATTCGCCCTTTCTTTAC	 Cloning	
Mib1_res_f	 agttgtcagaGGCCCGGACTGGAAGTGG	 Mutagenesis	
Mib1_res_r	 cttgcccctacCCCTTCCACCATCACCCG	 Mutagenesis	
3xFLAG-Mib1_f	 cgattacaaggatgacgatgacaagggtggaggcggttccAGTAACTCCCGGA
ATAAC	
Mutagenesis	
3xFLAG-Mib1_r	 atgtcatgatctttataatcaccgtcatggtctttgtagtcCATGAATTCACCGGA
AATAG	
Mutagenesis	
Mib1_C995S_f	 TGTCCTATCTcTCGCAAGGCTATTG	 Mutagenesis	
Mib1_C995S_r	 TTCACTCATGCGGTCTCC	 Mutagenesis	
Mib1_S805A_f	 GGGTTCTCGGgcTCCTTCTATGATTAGTAATG	 Mutagenesis	
Mib1_S805A_r	 ACTTGACCACTGACTTTTTC	 Mutagenesis	
Mib1_1-221_f	 TAAAGTAAAGAAAGGGCTAATTC	 Mutagenesis	
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Mib1_1-221_r	 GGCATCCTGGACACATTTC	 Mutagenesis	
Mib1_1-818_r	 CTCTTCTAAGGTTTCAGAATC	 Mutagenesis	
Mib1_222-1006_f	 AAGGGAGGTTCTTTCTACAGAGATC	 Mutagenesis	
Mib1_222-1006_r	 GGAACCGCCTCCACCCTT	 Mutagenesis	
M13r	 CAGGAAACAGCTATGACC	 Sequencing	
Mib1_seq	 AGCTGTGCCGTTGTCCCACA	 Sequencing	
 
 
